Cannabinoid liquid formulations for mucosal administration

Details for Australian Patent Application No. 2003253005 (hide)

Owner GW Pharma Limited

Inventors Whittle, Brian Anthony

Agent Davies Collison Cave

Pub. Number AU-B-2003253005

PCT Number PCT/GB03/03574

PCT Pub. Number WO2004/016246

Priority 10/218,989 14.08.02 US; 0218930.6 14.08.02 GB

Filing date 14 August 2003

Wipo publication date 3 March 2004

Acceptance publication date 19 March 2009

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

Event Publications

30 October 2003 Complete Application Filed

  Priority application(s): 10/218,989 14.08.02 US; 0218930.6 14.08.02 GB

22 April 2004 Application Open to Public Inspection

  Published as AU-B-2003253005

19 March 2009 Application Accepted

  Published as AU-B-2003253005

16 July 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003253006-Apparatus, and an associated method, for preserving service quality levels during hand-off in a radio communication system

2003253004-SUPPORTED POLYMERISATION CATALYSTS